CME Group Inc. -- 8.4/10 -- $305.11
CME Group is the world largest derivatives exchange, operating marketplaces across six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals, and foreign exchange. The company holds ~98% of US interest rate futures volume and owns exclusive licensing agreements for S&P 500, Nasdaq-100, Dow Jones, and Russell index futures -- extended through 2039 for Nasdaq alone. Together with ICE, CME forms an effective duopoly in listed derivatives, protected by network effects, cross-margining savings of ~$60B/day, and IP-protected benchmark products (SOFR, WTI, Henry Hub). CEO Terrence Duffy has led the company since 2006, delivering five consecutive years of record volume, four consecutive years of record revenue and EPS, and ~$3.9B in dividends in FY2025. The capex-light business model (~$85M annual CapEx on $6.5B revenue) converts virtually all earnings to cash. FY2025 adjusted diluted EPS reached $11.21, up 9.3% YoY, on revenue of $6.52B (+6.4% YoY). Market data revenue -- a high-quality, recurring stream -- has grown for 31 consecutive quarters and surpassed $800M annually. New growth vectors include crypto futures (record 379K ADV in Q4 2025), event contracts via a FanDuel JV (68M contracts in the first six weeks), 24/7 trading (announced for early 2026), and the SEC-approved CME Securities Clearing for treasury clearing.
| Price | $305.11 | FY2025 Revenue | $6.52B (+6.4% YoY) |
| Market Cap | $109B | FY2025 Adj. Diluted EPS | $11.21 (+9.3% YoY) |
| Analyst Consensus | Moderate Buy (~$301 mean PT) | FY2025 Adj. Operating Margin | 69.4% (+110bps YoY) |
| CEO | Terrence Duffy (since 2006) | FY2025 Total ADV | 28.1M contracts/day (5th record) |
| FY2026E Adj. EPS (consensus) | ~$11.73 (~26x fwd PE) | FY2025 Dividends Paid | ~$3.9B (regular + variable) |
| Dimension | Score | Weight | Weighted |
|---|---|---|---|
| Financial Trends | 8.5 | 25% | 2.13 |
| Thematic Exposure | 8.5 | 25% | 2.13 |
| Management Quality | 8.5 | 20% | 1.70 |
| Investor Sentiment (Inverted) | 8.0 | 15% | 1.20 |
| Concerns / Risks | 8.0 | 15% | 1.20 |
| Composite | 100% | 8.36 |
CME Group receives a composite score of 8.4/10, reflecting a premier monopoly franchise in global derivatives with an exceptional moat. Five consecutive years of record volume and four consecutive years of record revenue/EPS speak to an enduring structural growth story powered by expanding risk management needs, international growth, retail penetration, and product innovation. The moat is among the widest in financial services: exclusive index licenses, ~98% US rate futures share, and $60B/day in cross-margin savings create near-zero competitive displacement risk.
Management consistently delivers and returns capital generously (~$3.9B in FY2025 dividends). The capex-light model converts virtually all earnings to cash, supporting a 63% net margin that is exceptional in any industry. Adj. diluted EPS has compounded from $6.69 (FY2021) to $11.21 (FY2025), a 68% cumulative increase.
The key question for investors: At ~26x forward EPS with consensus expecting only ~5% growth in FY2026, is the risk/reward compelling enough for new capital? The valuation is a constraint -- there is limited room for multiple expansion. However, the under-appreciated optionalities provide asymmetric upside: event contracts (68M traded in first 6 weeks via FanDuel distribution to 13M accounts), treasury clearing mandate (multi-year call option on expanding the cleared treasury market), and crypto expansion (379K ADV, 24/7 trading launching in 2026). The primary risk is not competitive displacement but rather normalization of the elevated volatility environment that has driven five years of records.
Key catalysts and monitoring points:
- Rate volatility trajectory: Interest rate ADV is the single largest revenue driver. Monitor Fed policy signals, US debt trajectory ($36T+), and fiscal expansion. H2 2025 showed mean-reversion risk when rates ADV fell -10% YoY in Q3 as volatility receded.
- Event contracts scaling: 68M contracts in six weeks is remarkable traction. Track whether market-related event contracts (which management says are outpacing sports) create a bridge to traditional CME products and attract new customers from FanDuel distribution (13M accounts).
- Treasury clearing mandate execution: CME Securities Clearing was approved by the SEC in Dec 2025. Successful launch could meaningfully expand the addressable market for cleared treasuries -- a multi-year structural catalyst.
- Crypto and 24/7 trading: Record 379K ADV in Q4 2025 (+92% YoY). 24/7 trading announced for early 2026. Still <3% of revenue but directionally meaningful.
- Metals ADV surge sustainability: Q4 2025 metals ADV surged +114% YoY driven by gold at $3,500+/oz and the 1-ounce gold contract. Determine whether this is structural or cyclical.
- Expense discipline: Management guided $1.695B for FY2026 expenses. They beat FY2025 guidance by $25M cumulatively -- track whether this pattern continues.
- Capital return evolution: $256M in share repurchases initiated in Q4 2025 with $1.3B earmarked from the Austro JV sale. This is a new capital return lever beyond the generous regular + variable dividend program.
For the full risk matrix and valuation analysis, see the Valuation page.
Concerns, Catalysts & Risks -- full analysis
Core long position -- highest-quality monopoly franchise in financial infrastructure. The forward PE (~26x FY2026E) reflects the market premium for 60%+ net margins, recurring revenue characteristics, and a near-impenetrable competitive moat. The premium is justified but limits upside to earnings growth plus any re-rating from under-appreciated optionalities. At $305.11, the stock sits 7% below its all-time high with the mean analyst PT near current levels (~$301), suggesting the consensus view is fairly priced. The opportunity lies in the optionalities that consensus has not fully underwritten: event contracts via FanDuel (new TAM expansion), treasury clearing (structural market growth), and continued international penetration (record 8.4M ADV). Key position-sizing considerations: (1) volume mean-reversion risk after five consecutive record years, (2) rate environment normalization compressing the largest asset class, (3) regulatory uncertainty around event contracts and prediction markets, and (4) the ~26x multiple leaving limited margin of safety if growth disappoints. The exceptional moat, 63% net margin, and consistent capital returns provide durable downside protection while new product categories offer multi-year upside optionality.